Patients may require a combination therapy regime, including surgery, chemotherapy, radiation therapy and immunotherapy, among others. Although immunotherapy drugs for gastrointestinal cancers are ...

Researchers at WashU Medicine shrink gastrointestinal tumors in mice using a yeast probiotic to deliver immunotherapy to the gut, offering a potentially novel strategy to target hard-to-reach gut ...

For decades, the medical world has avidly searched for groundbreaking treatments against one of humanity’s most resilient ...

A new series of fluoroquinolone-based compounds were designed and synthesized as potential anticancer agents. A single-dose ...

Add articles to your saved list and come back to them any time. Medical technology innovator Algorae Pharmaceuticals has ...

Immunotherapy is a promising treatment that recruits the immune system to help fight cancer, but it has had limited success ...

Reports of GLP-1RA–associated acute kidney injury (AKI) have emerged, but the risk of GLP-1RA–associated AKI among patients on anti-cancer drugs is unclear. Surprisingly, new research suggests that ...

Ivosidenib is a targeted cancer drug. It is also known as Tibsovo. Azacitidine is a chemotherapy drug. It is also called Vidaza. You pronounce ivosidenib as i-voh-sih-deh-nib. And you pronounce ...

Annual BioTech Breakthrough Award is devoted to honoring excellence in life science and biotechnology solutions, services, ...